WN
PAHC icon

Williams & Novak’s Phibro Animal Health PAHC Stock Holding History

Williams & Novak’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,929
Closed -$196K – 133
2024
Q1 		$196K Hold
16,929
– – 0.22% 82
2023
Q4 		$196K Buy
+16,929
New +$191K 0.22% 82

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Williams & Novak's PAHC Position: Q2 2024 in Review

Williams & Novak sold out of Phibro Animal Health (PAHC) in Q2 2024, closing a stake of 16,929 shares — an estimated $196K sold.

Williams & Novak first reported a position in PAHC in Q4 2023 and held it in 2 quarters. The position peaked at $196K in Q1 2024. 141 funds tracked by Wall St. Rank hold PAHC as of Q2 2024.

  • Williams & Novak reported no remaining Phibro Animal Health position as of Q2 2024 after selling out during the quarter.
  • Williams & Novak sold 16,929 Phibro Animal Health shares in Q2 2024, an estimated $196K.
  • Williams & Novak first reported a position in Phibro Animal Health in Q4 2023 and held it in 2 quarters.
  • Williams & Novak's Phibro Animal Health position peaked at $196K in Q1 2024.
  • 141 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2024.

Based on Williams & Novak's 13F filing for Q2 2024, filed 12 Jul 2024.